Research and Development

Showing 15 posts of 9596 posts found.

Methylene blue poised to move into the clinic

February 24, 2010 Manufacturing and Production, Research and Development Novasep, ProveBlue, Provepharm, malaria

A new purer form of the reagent methylene blue could take the compound out of the testing laboratory and into …
IcahnWebV

Predatory Icahn moves in on weakened Genzyme

February 23, 2010 Research and Development, Sales and Marketing Gaucher, Genzyme, Icahn

Corporate raider Carl Icahn has made a bid to gain control of beleaguered Genzyme as it struggles to overcome major …
Avandia

Reports raise fresh Avandia safety questions

February 23, 2010 Research and Development, Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline’s troubled diabetes drug Avandia has been hit by fresh reports from the US that it increases the risk of …

Pfizer, Lilly and Merck partner for cancer research

February 23, 2010 Research and Development Asia, Cancer, developing world, em, emerging markets

Three pharma companies have formed a not-for-profit organisation, the Asian Cancer Research Group (ACRG), to boost work on treating common …

Digital Pharma: Searching for clinical trials

February 23, 2010 Research and Development CRO, TrialReach, digi, digital pharma, digital pharma research, digital research, patient recruitment

A new clinical trials search and referral engine has launched to help patients who are considering taking part in a …

Lilly UK appoints Ramona Sequeira managing director

February 23, 2010 Research and Development, Sales and Marketing appointment, lilly, research and development, sales and marketing

Lilly UK has appointed Ramona Sequeira managing director, UK and Republic of Ireland.She replaces Andrew Hotchkiss who becomes vice president …
Brain picture

Novartis gains edge in MS treatment race

February 22, 2010 Research and Development, Sales and Marketing Cladribine, Gilenia, MS, Novartis

Novartis’ new oral multiple sclerosis treatment Gilenia will be given a priority review by the FDA.This could lead to a …

ReNeuron to begin landmark stem cell trial for stroke

February 19, 2010 Research and Development ReNeuron, stem cell

ReNeuron has been given the go-ahead to begin clinical trials of the first ever stem cell therapy for patients disabled …

Clinipace appoints Bud Owen and Daryl Porter

February 19, 2010 Research and Development Clinipace, appointment, research and development

CRO and eClinical technology specialist Clinipace Worldwide has appointed Bud Owen as its chief financial officer, while Daryl Porter has …

Dr Jay Feingold joins Daiichi Sankyo

February 19, 2010 Research and Development Daiichi Sankyo, appointment, research and development

Daiichi Sankyo’s US arm has appointed Dr Jay Feingold vice president of medical affairs. In this role his will manage …

Merck’s HIV treatment fails in phase III

February 18, 2010 Research and Development HIV, Merck

Merck’s HIV treatment vicriviroc has disappointed in phase III trials, and may be dropped by the company. The results failed …
Money trap

Drug development: where’s the added investment value?

February 18, 2010 Research and Development CRO, Les Rose, R&D, biotech, funding

Venture capital is a curious business. The global financial crisis which we are slowly emerging from has exposed some rather …

Wyeth’s Dr Graham Cook joins British Pharmacopoeia Commission

February 18, 2010 Research and Development, Sales and Marketing Wyeth Pharmaceuticals, appointment, research and development, sales and marketing

Dr Graham Cook, a senior director in the Global Quality and Compliance division of Wyeth Pharmaceuticals, has joined the British …

Chiltern Opens New Office In Argentina

February 17, 2010 Research and Development

Oscar Podesta, Chiltern Executive Director, Latin America, leads this endeavor. “Our office, strategically located in suburban Pilar, is a natural …
The Gateway to Local Adoption Series

Latest content